11/3
07:31 am
rmd
Rating for RMD
Low
Report
Rating for RMD
11/3
07:31 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/31
11:07 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/31
11:07 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/31
09:09 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/31
09:09 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/31
08:02 am
rmd
Rating for RMD
Medium
Report
Rating for RMD
10/31
08:02 am
rmd
Rating for RMD
Medium
Report
Rating for RMD
10/21
08:04 am
rmd
ResMed (NYSE:RMD) had its "overweight" rating reaffirmed by analysts at Morgan Stanley. They now have a $304.00 price target on the stock, up previously from $298.00.
Low
Report
ResMed (NYSE:RMD) had its "overweight" rating reaffirmed by analysts at Morgan Stanley. They now have a $304.00 price target on the stock, up previously from $298.00.
10/21
08:04 am
rmd
ResMed (NYSE:RMD) had its "overweight" rating reaffirmed by analysts at Morgan Stanley. They now have a $304.00 price target on the stock, up previously from $298.00.
Low
Report
ResMed (NYSE:RMD) had its "overweight" rating reaffirmed by analysts at Morgan Stanley. They now have a $304.00 price target on the stock, up previously from $298.00.
10/21
07:52 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/21
07:52 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/14
07:59 am
rmd
ResMed (NYSE:RMD) was upgraded by analysts at Wells Fargo & Company to a "hold" rating.
Low
Report
ResMed (NYSE:RMD) was upgraded by analysts at Wells Fargo & Company to a "hold" rating.
10/13
09:00 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/13
09:00 am
rmd
Rating for RMD
Low
Report
Rating for RMD
10/13
06:48 am
rmd
ResMed initiated with an Equal Weight at Wells Fargo
Low
Report
ResMed initiated with an Equal Weight at Wells Fargo
10/13
06:48 am
rmd
ResMed initiated with an Equal Weight at Wells Fargo
Low
Report
ResMed initiated with an Equal Weight at Wells Fargo
9/20
09:52 am
rmd
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
9/18
08:09 am
rmd
ResMed (NYSE:RMD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $330.00 price target on the stock.
Low
Report
ResMed (NYSE:RMD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $330.00 price target on the stock.
9/18
07:19 am
rmd
Rating for RMD
Low
Report
Rating for RMD
9/18
07:19 am
rmd
Rating for RMD
Low
Report
Rating for RMD
9/18
06:38 am
rmd
ResMed U.S. shares initiated with a Buy at Citi
Low
Report
ResMed U.S. shares initiated with a Buy at Citi